CITIGROUP INC - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 186 filers reported holding DENALI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,853,314
-10.5%
138,309
+28.0%
0.00%0.0%
Q2 2023$3,187,876
-33.6%
108,027
-48.1%
0.00%
-33.3%
Q1 2023$4,800,154
+34.7%
208,340
+62.6%
0.00%0.0%
Q4 2022$3,563,017
-39.7%
128,120
-33.5%
0.00%
-25.0%
Q3 2022$5,913,000
+79.7%
192,642
+72.3%
0.00%
+100.0%
Q2 2022$3,291,000
+189.2%
111,814
+216.0%
0.00%
+100.0%
Q1 2022$1,138,000
-78.8%
35,384
-70.6%
0.00%
-66.7%
Q4 2021$5,369,000
-2.4%
120,381
+10.4%
0.00%0.0%
Q3 2021$5,500,000
+7.5%
109,025
+67.1%
0.00%0.0%
Q2 2021$5,118,000
+28.5%
65,247
-6.5%
0.00%0.0%
Q1 2021$3,984,000
+170.3%
69,774
+296.6%
0.00%
+200.0%
Q4 2020$1,474,000
+492.0%
17,595
+153.4%
0.00%
Q3 2020$249,000
-79.3%
6,944
-86.1%
0.00%
-100.0%
Q2 2020$1,205,000
+81.7%
49,864
+31.7%
0.00%0.0%
Q1 2020$663,000
+117.4%
37,864
+116.1%
0.00%
Q4 2019$305,000
-74.6%
17,522
-77.7%
0.00%
-100.0%
Q3 2019$1,203,000
-10.2%
78,517
+21.8%
0.00%0.0%
Q2 2019$1,339,000
+379.9%
64,483
+437.2%
0.00%
Q1 2019$279,000
-84.9%
12,003
-86.6%
0.00%
-100.0%
Q4 2018$1,845,000
+561.3%
89,314
+594.7%
0.00%
Q3 2018$279,000
+654.1%
12,856
+429.7%
0.00%
Q2 2018$37,000
-17.8%
2,427
+5.8%
0.00%
Q1 2018$45,0002,2950.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$339,037,00035.95%
Euclidean Capital LLC 323,749$27,117,0005.74%
Flagship Pioneering Inc. 2,730,263$228,687,0004.16%
Casdin Capital, LLC 1,310,000$109,726,0003.25%
A.R.T. Advisors, LLC 6,173$517,0002.39%
MARK ASSET MANAGEMENT LP 172,040$14,410,0001.73%
Temasek Holdings (Private) Ltd 4,410,457$369,420,0001.59%
Integral Health Asset Management, LLC 57,500$4,816,0001.43%
GILDER GAGNON HOWE & CO LLC 3,219,843$269,694,0001.34%
IRONWOOD INVESTMENT MANAGEMENT LLC 19,365$1,622,0000.95%
View complete list of DENALI THERAPEUTICS INC shareholders